AVLSA
Atlas Venture Life Science Advisors’s Dianthus Therapeutics DNTH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-76,979
| Closed | -$2.11M | – | 14 |
|
|
2024
Q3 | $2.11M | Sell |
76,979
-60,000
| -44% | -$1.64M | 0.2% | 13 |
|
|
2024
Q2 | $3.55M | Sell |
136,979
-50,000
| -27% | -$1.29M | 0.37% | 13 |
|
|
2024
Q1 | $5.61M | Sell |
186,979
-50,000
| -21% | -$1.5M | 0.52% | 14 |
|
|
2023
Q4 | $2.46M | Hold |
236,979
| – | – | 0.29% | 14 |
|
|
2023
Q3 | $3.24M | Sell |
236,979
-3,554,719
| -94% | -$48.6M | 0.5% | 14 |
|
|
2023
Q2 | $2.87M | Hold |
3,791,698
| – | – | 0.36% | 14 |
|
|
2023
Q1 | $3.01M | Buy |
3,791,698
+315,162
| +9% | +$250K | 0.41% | 14 |
|
|
2022
Q4 | $1.37M | Hold |
3,476,536
| – | – | 0.17% | 17 |
|
|
2022
Q3 | $4.9M | Hold |
3,476,536
| – | – | 0.54% | 13 |
|
|
2022
Q2 | $4.17M | Hold |
3,476,536
| – | – | 0.7% | 12 |
|
|
2022
Q1 | $10.1M | Hold |
3,476,536
| – | – | 1.27% | 11 |
|
|
2021
Q4 | $15.4M | Buy |
+3,476,536
| New | +$15.4M | 1.41% | 12 |
|